0RGI fundamentals
COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) financial statements, including revenue, expenses, profit, and loss
The total revenue of 0RGI for the last semiannual is 50.81 M CHF, and it's 18.09% higher compared to the previous semiannual. The net income of H2 23 is -133.11 k CHF.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CHF
TTM